Bookbuilding IPO | ₹[.] Cr | Listing at BSE SME |
Goldline Pharmaceutical Ltd. IPO is a Book Build Issue consisting solely of fresh issue of upto 0.30 crore equity shares.
The equity shares are proposed to be listed on the BSE SME. Cumulative Capital Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. Key details like IPO dates, IPO price bands and lot size are yet to be announced.
Refer to Goldline Pharmaceutical IPO DRHP for more details.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Total Issue Size | 30,00,000 shares (agg. up to ₹[.] Cr) |
| Fresh Issue | 30,00,000 shares (agg. up to ₹[.] Cr) |
| Share Holding Pre Issue | 69,00,000 shares |
| Share Holding Post Issue | 99,00,000 shares |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Tue, Sep 30, 2025 |
| SEBI/Exchange approval received | Mon, Jan 19, 2026 |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Issue size |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII Shares Offered | Not more than 15% of the Net Issue |
Goldline Pharmaceuticals is engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” Its product range is divided into five segments:
The company do not manufacture products, it partner with third-party manufacturers who produce the medicines based on its market research and product specifications, ensuring quality and compliance with regulations.
All products are marketed and sold under the Goldline brand through our network of distributors, who supply to retailers and wholesalers. The company currently works with 15 manufacturers and 7 distributors, and it also support hospitals and healthcare providers with procurement and material supply.
The company sells products across the states of Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.
Competitive Strengths:
Goldline Pharmaceutical Ltd.'s revenue increased by 19% and profit after tax (PAT) rose by 57% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 26.28 | 22.93 | 19.39 |
| Total Income | 28.06 | 23.57 | 19.85 |
| Profit After Tax | 2.83 | 1.81 | 0.26 |
| EBITDA | 5.83 | 4.30 | 2.19 |
| NET Worth | 10.35 | 7.87 | 5.89 |
| Reserves and Surplus | 1.65 | 3.76 | 2.08 |
| Total Borrowing | 11.03 | 11.13 | 10.83 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our company | 8.90 |
| 2 | General corporate purposes |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 35.84% |
| ROCE | 38.46% |
| Debt/Equity | 1.50 |
| RoNW | 27.38% |
| PAT Margin | 10.10% |
| EBITDA Margin | 20.79% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 79.70% |
Lead Manager Reports
Goldline Pharmaceutical IPO is a SME IPO of 30,00,000 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at To be declared. The minimum order quantity is .
The Goldline Pharmaceutical IPO open and close dates are not available as of now.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Goldline Pharmaceutical IPO using UPI as a payment gateway. Zerodha customers can apply in Goldline Pharmaceutical IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Goldline Pharmaceutical IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Goldline Pharmaceutical IPO dates are not announced. Please check back again after some time.
Goldline Pharmaceutical IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Goldline Pharmaceutical IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Goldline Pharmaceutical IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Goldline Pharmaceutical IPO allotment status.
The Goldline Pharmaceutical IPO listing date is not yet announced. The tentative date of listing is .
